Published on 10 Jan 2020:

Meticulous Research®– leading global market research company published a research report titled Oligonucleotide Synthesis Market by Product & Service (Synthesizer, Custom Oligonucleotide Synthesis Service, Probes, Primers, Linkers & Adaptor, Reagents & Consumables), Application (Research, Therapeutics, Diagnostics), and End User – Global Forecast to 2025”.

According to this latest publication from Meticulous Research®, the global oligonucleotide synthesis market is expected to grow at a CAGR of 10.4% from 2019 to reach $3.9 billion by 2025. The growth in the oligonucleotide synthesis market is mainly attributed to the growing adoption of synthesized oligonucleotides in diagnostic and clinical applications, rising R&D expenditure and government investment in pharmaceutical and biotechnology companies, plummeting cost of sequencing, increasing public & private spending on genomics, and rising venture capital investments/funding. However, factors such as lack of regulations for therapeutic oligos and price erosion of synthesized oligonucleotides are likely to restrain the market growth during the forecast period. In addition, large scale synthesis of oligonucleotides and delivery of oligonucleotide drugs to specific target are recognized as the major hurdles to overcome.

Growth Prospects in the Oligonucleotide Synthesis Market

The global oligonucleotide synthesis market study presents historical market data in terms of value (2017 and 2018), estimated current data (2019), and forecasts for 2025-by product & services [synthesized oligonucleotide (primers, probes, and linkers & adapters), oligonucleotide synthesis product (reagents & consumables, equipment), custom oligonucleotide synthesis services (Intermediate scale, large scale, and small scale oligonucleotides)], application [research (PCR, qPCR/RTqPCR, sequencing, genes synthesis, and, other research applications), diagnostics, therapeutics (RNAi oligonucleotide-based therapies, DNA/antisense oligonucleotide-based therapies, immunotherapy {CpG oligonucleotide-based therapies}, and nucleic acid aptamers), end user (pharmaceutical and biotechnology companies, academic research institutes, diagnostic laboratories, and others), and geography. The study also evaluates industry competitors and analyzes the market at a regional and country level.

Based on application, research applications segment is estimated to hold the largest share of the overall oligonucleotide synthesis market in 2019, owing to the rising adoption of oligonucleotides in drug discovery & development studies with the recent developments in the gene synthesis and next generation sequencing areas. However, use of oligonucleotides for diagnostic applications is expected to grow at the fastest CAGR during the analysis period, mainly due to developing applications of molecular diagnostics (MDx) and genetic testing.

Check complete table of contents with list of table and figures:https://www.meticulousresearch.com/product/oligonucleotide-synthesis-market-4953/

Geographic Review:

This research report analyzes major geographies and provides comprehensive analysis for North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of Asia-Pacific), Latin America, and the Middle East & Africa.

North America region is estimated to command the largest share of the global oligonucleotide synthesis market in 2019, closely followed by the Europe, and Asia Pacific. However, Asia Pacific region is slated to register the fastest growth during the forecast period, primarily due to rising availability of synthesized oligonucleotides, strong presence of pharma & biotech companies, growing clinical research & trial outsourcing to CROs, and increase in R&D funding and activities in the APAC region.

Key Players:

The key players operating in the global oligonucleotide synthesis market are Integrated DNA Technologies, Inc. (U.S.) (Part of Danaher Corporation), Merck KGaA (Germany), Eurofins Scientific SE (Luxembourg), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), GE Healthcare (U.S.), GeneDesign, Inc. (Japan) (Part of Ajinomoto Co.,Inc.), Kaneka Eurogentec (Belgium) (Part of Kaneka Corporation), LGC Biosearch Technologies (U.S.), Bio-synthesis Inc. (U.S.), TriLink BioTechnologies, LLC (U.S.) (Part of Maravai LifeSciences), and ATDBio Ltd. (U.K.) among others.

Key questions answered in the report-

  • Which are the high growth market segments in terms of product & service, technology, application, end user, and region/countries?
  • What was the historical market for oligonucleotide synthesis across the globe?
  • What are the market forecasts and estimates for the period 2019–2025?
  • What are the major drivers, restraints, challenges, and opportunities in the global oligonucleotide synthesis market?
  • Who are the major players in the global oligonucleotide synthesis market?
  • How is the competitive landscape and who are the market leaders in the global oligonucleotide synthesis market?
  • What are the different strategies adopted by the major players operating in the global oligonucleotide synthesis market?
  • What are the key geographical trends and which are high growth regions/countries?

Contact Us:

Meticulous Research®

Email- sales@meticulousresearch.com

Contact Sales- +1-646-781-8004

Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

Download Free Sample